If any medication remains unused beyond the recommended beyond-use or expiration date, it should be disposed of properly
Today, there are numerous GLP-1 agonists being developed and trialed for the treatment of obesity
An analysis of nearly 10,000 people taking semaglutide drugs found they lost on average 10.2-13.2% of baseline weight over 12 months.(8) Its important to note that GLP-1 clinical trials employ run-in periods where non-adherent participants are excluded.(9) Real world patients face many barriers to consistent adherence, including side effects, injection anxieties, medication costs and behavioral challenges
Agarwal A, Said TM, Bedaiwy MA, Banerjee J, Alvarez JG: Oxidative stress in an assisted reproductive techniques setting
It's important to consult with a healthcare professional before beginning any new supplement regimen, especially if you have underlying health conditions or are taking medications